Selected Publications
Kim A. Reiss, Mathew G. Angelos, E. Claire Dees, Yuan Yuan, Naoto T. Ueno, Paula R.Pohman, Melissa L. Johnson, Joseph Chao, Olga Shestova, Jonathan S. Serody, Maggie Schmierer, Madison Kremp, Michael Ball, Rehman Qureshi, Benjamin H. Schott, Poonam Sonawane, Sabrina Ceeraz DeLong, Melissa Christiano, Ramona F. Swaby, Sascha Abramson, Ken Locke, Debora Barton, Eugene Kennedy, Saar I. Gill, Daniel Cushing, Michael Klichinsky, Thomas Condamine, Yara Abdou: Chimeric antigen receptor macrophage therapy for HER2-overexpressing advanced solid tumors: A phase 1, first-in-human clinical trial Nature Medicine : 2025.
Alison M. Schram, Koichi Goto, Dong-Wan Kim, Teresa Macarulla, Antoine Hollebecque, Eileen M. O’Reilly, Sai-Hong Ignatius Ou, Jordi Rodon Ahnert, Sun Young Rha, Kazumi Nishino, Michaël Duruisseaux, Joon Oh Park, Cindy Neuzillet, Stephen V. Liu, Benjamin A. Weinberg, James M. Cleary, Emiliano Calvo, Kumiko Umemoto, Misako Nagasaka, Christoph Springfeld, Tanios Bekaii-Saab, Grainne M. O’Kane, Frans Opdam, Kim A. Reiss, Andrew K. Joe, Ernesto Wasserman, Viktoriya Stalbovskaya, Jim Ford, Shola Adeyemi, Lokesh Jain, Shekeab Jauhari, Alexander Drilon: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer NEJM : 2025.
Efrat Dotan, Paul J. Catalano, Leon Lenchik, Robert Boutin, Xin Yao, James Ohr, Kian-Huat Lim, George A. Fisher Jr., Namrata Vijayvergia, Sreenivasa R. Chandana, Aparna Kalyan, Richard F. Dunne, David B. Zhen, Daneng Li, Kim A. Reiss, Melissa A. Simon, Jordan Berlin, Lynne I. Wagner, Peter J. O'Dwyer: Effect of baseline geriatric and quality of life assessments on treatment outcomes in ECOG-ACRIN EA2186 (GIANT): A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer ASCO GI, San Francisco, CA : 2025.
Vincent Chung, Katherine A. Guthrie, Michael J. Pishvaian, Andrew M. Lowy, Davendra Sohal, Kim Anna Reiss, Nina Niu Sanford, Carmen Allegra, Sarah Colby, Eileen M. O'Reilly, E. Gabriela Chiorean, Philip Agop Philip: Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in patients with metastatic pancreatic cancer with germline BRCA1 or BRCA2 mutations: SWOG S2001 NCT04548752 ASCO GI, San Francisco, CA : 2025.
Celeste Simon, Xu Han, Michelle Burrows, Laura C Kim, Jimmy P Xu, Will Vostrejs, Van Le, Yangqing Jiang, Edna Cukierman, Ben Stanger, Clementina Mesaros, Brian Keith, Carson Poltorack, Kim Reiss, Sydney Shaffer: Cancer associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment Cell Reports : 2024.
Julia C. D’Souza MD, MS, Diana van Houten CRNP, Kim A. Reiss MD, Roger B. Cohen MD, John A. Kosteva MD, Charles J. Schneider MD, , Jennifer R. Eads MD, Ursina R. Teitelbaum MD, Michael C. Soulen MD: Initial Outcomes of Integrating Yttrium-90 Radioembolization with Capecitabine-Temozolomide for Grade 3 Liver-Dominant Metastatic Neuroendocrine Tumors NANETS Annual Meeting : 2024.
Minh T. Than, Mark O’Hara, Ben Z. Stanger, Kim A. Reiss: KRAS-driven Tumorigenesis and KRAS-driven Therapy in Pancreatic Adenocarcinoma Molecular Cancer Therapeutics : 2024.
Sriram Anbil, Nicholas Seewald, Elena G. Chiorean, Erika P. Hamilton, Maen Hussein, Pashtoon Kasi, Zulfiqar Malik, James A. Reeves, Gary K. Schwartz, Geoffrey Shapiro, Kevin K. Lin, Kenton Wride, Heidi Giordano, Lara Maloney, Karen McLachlan, Tanya Kwan, Hanna Tukachinsky, Alexa B Schrock, Shuogo Wang, Ethan S. Sokol, Brennan Decker, Katherine L. Nathanson, Susan M. Domchek, Kim A. Reiss: LODESTAR: A Single Arm Phase II Study of Rucaparib in Solid Tumors with Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes AACR Pancreas Meeting : 2024.
Kelsey S. Lau-Min, MD, MSCE; Heather Symecko, MPH; Kelsey Spielman, MS, CGC; Ryan Hood, BA; Peter Gabriel, MD, MSE; Katharine A. Rendle, PhD, MPH; Katherine L. Nathanson, MD, 6; Kim A. Reiss, MD; Susan M. Domchek, MD: Integration of Germline Genetic Testing into Routine Clinical Practice for Patients with Pancreatic Adenocarcinoma JCO Precision Oncology : 2024.
Erica Carpenter, Jacob Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon Pfeiffer, Jaclyn Lyman, Lacey Padron, Deena Maurer, Jia Xin Yu, Christine Spencer, Pier Gherardini, Diane Da Silva, Theresa LaVallee, charles Abbott, Richard Chen, Sean Michael Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Karasic, Charles Schneider, Peter O'Dwyer, Ursina Teitelbaum, Kim Reiss Binder, Osama Rahma, George Fisher, Andrew Ko, Zev Wainberg, Robert Wolff, Eileen O'Reilly, Mark O'Hara, Christopher Cabanski, and Robert Vonderheide: Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma Nature Communications : 2024.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-360-0735
Patient appointments: 800-789-7366